PPARG and lung carcinoma: As PPAR-γ is believed to act as a tumor suppressor in lung cancer development, we hypothesized that PPAR-γ promoter would be hypermethylated in all tumor samples, and that frequency of hypermethylation would be greater in the more biologically aggressive cancer (metastatic OSA) than in primary lung tumors.